AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on August 14, 2026

NIPES Announces Winners of the 2026 Award of Excellence, Second Cycle
KnifeLegends Highlights the Craftsmanship of Charly Bennica and Steve Johnson
Western Specialty Contractors Completes Sidewalk Waterproofing Project at Boston Office Building
 Quantum in 2026 looks exactly like crypto in 2013, says Karnika E. Yashwant after Chairing Track at Quantum.Tech World
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Rony Jabour Brings SAFE Tour to Rio de Janeiro for Brazil’s Workplace Safety Professionals
Global Water-Soluble Films Market to Reach $798.8 Million by 2031, Driven by Plastic Ban Regulations and Rising Demand for Sustainable Packaging
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
CSPi Reports FY2026 Third Quarter Results
Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update
A free, AI-powered youth entrepreneurship platform, “Dear Dreamer,” launches, built at the Martin Trust Center for MIT Entrepreneurship and made possible through a gift by the Frank & Eileen Foundation
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.